Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
3.950
+0.960 (32.11%)
At close: Aug 13, 2025, 4:00 PM
3.480
-0.470 (-11.90%)
Pre-market: Aug 14, 2025, 9:20 AM EDT
SONN Market Cap
SONN has a market cap or net worth of $24.74 million as of August 14, 2025. Its market cap has increased by 451.34% in one year.
Market Cap
24.74M
Enterprise Value
24.49M
1-Year Change
451.34%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $24.74M, a decrease of -57.41%. That is a compound annual growth rate of -14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 18.73M | 326.57% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |